Forza X1, Inc.
(FRZA)
Monteverde & Associates Announces the Investigation of Forza X1, Inc.
Titan Pharmaceuticals, Inc.
(TTNP)
Monteverde & Associates Announces the Investigation of Titan Pharmaceuticals, Inc.
Stronghold Digital Mining, Inc.
(SDIG)
Monteverde & Associates Announces the Investigation of Stronghold Digital Mining, Inc.
Inflection Point Acquisition Corp. II
(IPXX)
Monteverde & Associates Announces the Investigation of Inflection Point Acquisition Corp. II
Cyclo Therapeutics, Inc.
(CYTH)
Monteverde & Associates Announces the Investigation of Cyclo Therapeutics, Inc.
Vector Group Ltd.
(VGR)
Monteverde & Associates Announces the Investigation of Vector Group Ltd.
Terran Orbital Corporation
(LLAP)
Monteverde & Associates Announces the Investigation of Terran Orbital Corporation
Arch Resources, Inc.
(ARCH)
Monteverde & Associates Announces the Investigation of Arch Resources, Inc.
Fortune Rise Acquisition Corporation
(FRLA)
Monteverde & Associates Announces the Investigation of Fortune Rise Acquisition Corporation
Pieris Pharmaceuticals, Inc.
(PIRS)
Monteverde & Associates Announces the Investigation of Pieris Pharmaceuticals, Inc.
Revance Therapeutics, Inc.
(RVNC)
Monteverde & Associates Announces the Investigation of Revance Therapeutics, Inc.
GSE Systems, Inc.
(GVP)
Monteverde & Associates Announces the Investigation of GSE Systems, Inc.
G1 Therapeutics, Inc.
(GTHX)
Monteverde & Associates Announces the Investigation of G1 Therapeutics, Inc.
Blue Owl Capital Corporation III
(OBDE)
Monteverde & Associates Announces the Investigation of Blue Owl Capital Corporation III
